Visalytics
Visalytics
approved EB-2 (NIW)

Researcher

Epidemiology · Denmark · 2023-02-08

Processing Time
27 days
Decision Date
2023-02-08
Location
California
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop new diagnostic and treatment selection tools to optimize the management of cancer, specifically focusing on technologies like prostate segmentation for biopsies. This work aims to improve accuracy in procedures performed by physicians to reduce mortality rates and enhance personalized treatment outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses cancer, a leading national concern in the U.S. with 1.9 million new cases annually, providing essential improvements in diagnostic tools.

2 Well-positioned to Advance the Endeavor Met

The petitioner has a strong record of 15 peer-reviewed articles, 164 citations, and has been supported by funding from the NIH and NCI.

3 Waiver Benefit Met

On balance, the U.S. benefits from waiving the labor certification to expedite research that reduces cancer mortality and improves prognosis.

Why This Petition Was Approved

The petition was approved based on the petitioner's 15 peer-reviewed journal articles, 2 conference papers, and 2 invited publications which garnered 164 citations. Additionally, the petitioner completed 80 peer reviews and demonstrated 3 years of direct research experience supported by funding from the NIH and NCI, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Conference Presentations
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Others

Healthcare · Ireland

WeGreened EB-2 (NIW) approved
19 days 2025-05-05
The petitioner proposes to apply patient-centered analytics and AI-based modeling to improve decision-making and personalize care for prostate cancer. The work focuses on developing predictive models for prostatectomy outcomes and robotic surgical techniques to stratify risk and tailor clinical interventions. This endeavor aims to reduce patient morbidity and mortality through earlier diagnoses and better-informed surgical decisions.
View Case

Postdoctoral Researcher

Research and Development · Japan

WeGreened EB-2 (NIW) approved
Maryland 63 days 2022-04-25
The petitioner proposes to continue developing liquid-based, non-invasive biomarker identification and cancer treatment strategies to advance innovations in the care of prostate cancer patients. Her work focuses on the development of novel detection and treatment protocols for metastatic castration-resistant prostate cancer (mCRPC) to improve patient outcomes and quality of life.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Doctor

Healthcare · China

WeGreened EB-2 (NIW) rfe approved
169 days 2025-06-11
The petitioner proposes to continue his work in personalized oncology by developing tailored treatment regimens based on molecular diagnostics and tumor genomics. His research focuses on refining patient stratification to enable more effective and less toxic cancer therapies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from Denmark

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 27 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Denmark All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist